查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1494582

患者參與技術市場評估：依組件、交付類型、治療領域、功能、應用、最終用戶和地區劃分的機會和預測（2017-2031）

Patient Engagement Technology Market Assessment, By Component, By Delivery Type, By Therapeutic Area, By Functionality, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 234 Pages | 商品交期: 3-5個工作天內

價格

全球患者參與技術市場規模將從 2023 年的 204.1 億美元增長到 2031 年的 627.8 億美元，預計在 2024 年至 2031 年的預測期內將以 15.08% 的複合年增長率增長。

市場的成長受到有利的政府政策的出台、人口的快速增長、各種疾病的流行、行動應用程式的使用增加以及各參與者之間的戰略合作夥伴關係的支持。各種醫療機構為加強 IT 基礎設施而增加的投資也推動了患者參與技術的全球市場規模。這些技術提供的無縫患者幫助使醫療保健專業人員能夠有效追蹤患者的依從性，同時確保與患者的即時連接。

此外，領先公司增加對患者參與新創公司的投資預計將支持未來幾年的市場擴張。2024 年 4 月，Providence分拆了 Praia Health。Praia Health 是一個平台，旨在透過將患者與有用的服務和資源聯繫起來，幫助醫療保健提供者與患者建立更牢固的關係。A 輪融資由 Frist Cressey Ventures 完成，融資金額為 2,000 萬美元，Providence Ventures, Inc.、SignalFire Management Services, LLC、Epsilon Health Investors, LLC 等參與其中。該平台旨在統一分散的點解決方案和資料來源，包括計費和護理服務、護理導航和消費者級預訂。此類平台的開發將使患者旅程個人化，並為醫療保健專業人員提供對患者健康狀況的準確瞭解。

慢性病的增加將推動市場需求：

全球不同地區慢性病患者數量的增加也是支持市場擴張的關鍵驅動因素之一。根據U.S. Centers for Disease Control and Prevention估計，截至2024年，約有3,840萬人，即美國人口的11.6%，將患有糖尿病。預計各公司將投資開發以患者為中心的參與解決方案，以確保有效管理此類疾病。

該報告調查了全球患者參與技術市場，並提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構、影響市場增長的因素分析以及案例研究。簡介等

目錄

第1章 研究方法論

第2章 專案範圍與定義

第3章 執行摘要

第4章 全球病患參與技術市場展望

  • 市場規模/預測
  • 依組件
    • 軟件
    • 硬件
    • 服務
  • 依交貨類型
    • 本地
    • 網路和雲端的
  • 依治療領域
    • 健康/保健
    • 慢性病管理
    • 其他
  • 依功能
    • 溝通
    • 健康追蹤/分析
    • 帳單/付款
    • 程式
    • 病患教育
    • 其他
  • 依用途
    • PHM (Population Health Management)
    • 住院病人健康管理
    • 門診健康管理
    • 其他
  • 依最終用戶
    • 醫療服務提供方
    • 保險公司
    • 病人
    • 其他
  • 依地區
    • 北美
    • 歐洲
    • 南美洲
    • 亞太地區
    • 中東/非洲
  • 依公司劃分的市場佔有率

第五章全球病患參與技術市場展望：依地區

  • 北美
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第 6 章 市場測繪，2023 年

  • 依組件
  • 依交貨類型
  • 依治療領域
  • 依功能
  • 依用途
  • 依最終用戶
  • 依地區

第7章 宏觀環境與產業結構

  • 供需分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第八章市場動態

  • 成長動力
  • 生長抑制因素（問題/限制）

第9章 監理架構與創新

  • 專利情況
  • 監管審批
  • 創新/新興技術

第十章 主要公司情況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 名市場領導者的市場收入分析
  • 併購/合資（如適用）
  • SWOT分析（5家參與企業）
  • 專利分析（如果適用）

第11章 價格分析

第12章 案例研究

第13章 主要公司展望

  • Oracle Corporation
  • IQVIA Holdings Inc.
  • Koninklijke Philips N.V.
  • Klara Technologies, Inc.
  • Oneview Healthcare PLC
  • Epic Systems Corporation
  • Lincor Inc.
  • Orion Health Ltd.
  • MEDHOST Inc.
  • Nuance Communications, Inc.

第14章 戰略建議

第15章 關於我們公司/免責聲明

Product Code: MX11457

Global patient engagement technology market is projected to witness a CAGR of 15.08% during the forecast period 2024-2031F, growing from USD 20.41 billion in 2023 to USD 62.78 billion in 2031F. The market's growth is supported by the introduction of favorable government policies, rapid population growth, the increasing prevalence of various diseases, the rising usage of mobile applications, and strategic partnerships between various market players. The rising investments towards enhancing IT infrastructure by various healthcare establishments are bolstering the global patient engagement technology market size. The seamless patient assistance offered by these technologies allows healthcare professionals to track patient adherence effectively while ensuring a real-time connection with the patients.

Additionally, the increasing investments by leading companies towards patient engagement startups are expected to support the expansion of the market in the coming years. In April 2024, Providence spun out Praia Health, a platform designed to aid healthcare providers in building strong relationships with their patients by connecting them to helpful services and resources. The Series A funding round was closed at USD 20 million by Frist Cressey Ventures and includes participants such as Providence Ventures, Inc., SignalFire Management Services, L.L.C., and Epsilon Health Investors, LLC. The platform aims to unify fragmented point solutions and data sources, including those designed for billing and care delivery, care navigation, and booking appointments at the consumer level. With the development of such platforms, personalization of the patients' healthcare journeys will become possible, and the healthcare professionals will be provided with an accurate picture of the patient's health.

Increasing Prevalence of Chronic Diseases Boosts Market Demand

The rise in the number of patients living with various chronic diseases in various regions across the globe is one of the major drivers supporting the expansion of the market. According to the estimates of the U.S. Centers for Disease Control and Prevention, approximately 38.4 million individuals (accounting for 11.6% of the population of the United States) are living with diabetes as of 2024. Thus, various companies should be encouraged to invest in the development of patient-centric engagement solutions to ensure the effective management of such diseases.

Patient engagement technologies increase the patient's information accessibility and improve healthcare outcomes. They are also responsible for reducing expenses by streamlining workflow and improving patient coordination. In November 2023, Prisma Health, the largest healthcare provider in South Carolina, announced that they saved USD 4 million within the first two years by incorporating digital patient communication. The healthcare provider made these savings with the help of Artera, the patient engagement company. Meanwhile, to enhance the quality of care provided to the patients, the emphasis on developing novel technologies and launching advanced products is also increasing, resulting in the introduction of novel patient engagement solutions.

Rising Mergers, Collaborations and Acquisitions Support Market Growth

The increasing investments by various companies in developing novel products and software are expected to provide lucrative growth opportunities for the market in the coming years. Such activities support the development of novel products and technologies and allow companies to expand their customer base, increasing patient accessibility to various technologies. In January 2024, Innovaccer Inc., the leading digital healthcare company, announced the acquisition of Cured Inc., a CRM and healthcare digital marketing platform. The deal allowed the digital healthcare company to add 20 new customers to its portfolio of approximately 95 digital health and health system clients. Some of Cured's customers include HonorHealth, VCU Health, Sutter Health, and UCHealth. The accusation is expected to aid Innovaccer in becoming a leader in patient experience technology and execute its forward strategy.

North America Accounts for a Significant Share of the Market

The growth of the market in the region can be attributed to the increasing emphasis on enhancing the quality of care provided to patients, the rapid expansion of the healthcare sector, the strong presence of leading market players, and the rising acceptance of advanced technologies and services. Patient engagement technology allows healthcare professionals to gather actionable patient health data, reducing costs for healthcare providers and patients and enhancing the patient experience, thus bolstering their utilization. The growing efforts of the various companies based in the region towards developing advanced solutions are also supporting the market expansion. For instance, in September 2023, Zocdoc, Inc., one of the leading appointment booking platforms, launched its free suite of tools to aid healthcare providers in managing, keeping, and reaching patients. The company is expected to continue its efforts to support the enhancement of the tools, provide patient-provider messaging, and incorporate additional services such as facilitation of payments, among others, to bolster patient engagement and save time on different admin tasks. Such developments are also expected to support the growth of the region's market in the coming years.

Software Account for Significant Global Patient Engagement Technology Market Share

The software segment will account for a significant market share in the coming years. This growth can be attributed to various healthcare institutions' rising adoption of software to streamline workflow and provide enhanced patient experience. Furthermore, such software also aids in improving the quality of care provided for various chronic diseases and disorders, including cancer. According to the estimates of the National Cancer Institute, in 2022, 20 million new cases of cancer were reported, and the number is expected to increase to 29.9 million by 2040. This increase in cancer cases is propelling the requirement for patient engagement software to enhance oncology care as the software ensures focused patient interaction while providing intelligent symptom management and enabling digital patient monitoring.

Future Market Scenario (2024-2031F)

According to the global patient engagement technology market analysis, the market is expected to receive lucrative growth opportunities in the coming years. Patient engagement tools are expected to be used in research studies as an intervention or treatment for various diseases and disorders. For instance, Stanford University is conducting an interventional study that is expected to conclude in August 2025 to improve access and adherence to overactive bladder treatment with the help of mobile technology-based interventions and personalized behavioral modifications. The study aims to evaluate the effectiveness of a patient-centered tool in initiating the treatment.

Technological innovations in patient engagement are expected to deliver digital healthcare transformation in the coming years. Omnichannel healthcare is expected to become an integral component of healthcare digitalization, aiding patients in receiving a unified pathway to enhance their experience. The digital transformation of the healthcare sector with the help of artificial intelligence is expected to drive the market's growth. Artificial intelligence will allow the completion of various repetitive operations and tasks time-efficiently, enhancing patient experience and ensuring a deeper engagement among patients and their doctors.

Key Players Landscape and Outlook

The increasing partnerships between various market players support the market's growth to elevate the quality of care provided to patients. In April 2024, Linkwell Health, a healthcare-based consumer engagement technology company and Matrix Medical Network, one of the leading providers of in-home health assessments, announced a partnership to boost engagement with Matrix's services and enhance the patient experience. Matrix will be supported by Linkwell with omni-channel engagement journeys to encourage health plan members to take charge of their health. Linkwell's leading patient activation and engagement capabilities are expected to aid the organization in focusing on their core expertise.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Patient Engagement Technology Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. By Component
    • 4.2.1. Software
      • 4.2.1.1. Integrated Software
      • 4.2.1.2. Standalone Software
    • 4.2.2. Hardware
      • 4.2.2.1. Tablets
      • 4.2.2.2. In-room Television
      • 4.2.2.3. Integrated Bedside Terminals/Assisted Devices
    • 4.2.3. Services
      • 4.2.3.1. Consulting
      • 4.2.3.2. Support and Maintenance
      • 4.2.3.3. Training and Implementation
      • 4.2.3.4. Others
  • 4.3. By Delivery Type
    • 4.3.1. On Premise
    • 4.3.2. Web and Cloud-based
  • 4.4. By Therapeutic Area
    • 4.4.1. Health and Wellness
    • 4.4.2. Chronic Disease Management
    • 4.4.3. Others
  • 4.5. By Functionality
    • 4.5.1. Communication
    • 4.5.2. Health Tracking and Insights
    • 4.5.3. Billing and Payments
    • 4.5.4. Administrative
    • 4.5.5. Patient Education
    • 4.5.6. Others
  • 4.6. By Application
    • 4.6.1. Population Health Management
    • 4.6.2. In-patient Health Management
    • 4.6.3. Outpatient Health Management
    • 4.6.4. Others
  • 4.7. By End-user
    • 4.7.1. Healthcare Providers
      • 4.7.1.1. Ambulatory Care Centers
      • 4.7.1.2. Home Healthcare Providers
      • 4.7.1.3. Hospitals
    • 4.7.2. Payers
      • 4.7.2.1. Public
      • 4.7.2.2. Private
    • 4.7.3. Patients
    • 4.7.4. Others
  • 4.8. By Region
    • 4.8.1. North America
    • 4.8.2. South America
    • 4.8.3. Europe
    • 4.8.4. Asia-Pacific
    • 4.8.5. Middle East and Africa
  • 4.9. By Company Market Share (%), 2023

5. Global Patient Engagement Technology Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
    • 5.1.2. By Component
      • 5.1.2.1. Software
        • 5.1.2.1.1. Integrated Software
        • 5.1.2.1.2. Standalone Software
      • 5.1.2.2. Hardware
        • 5.1.2.2.1. Tablets
        • 5.1.2.2.2. In-room Television
        • 5.1.2.2.3. Integrated Bedside Terminals/Assisted Devices
      • 5.1.2.3. Services
        • 5.1.2.3.1. Consulting
        • 5.1.2.3.2. Support and Maintenance
        • 5.1.2.3.3. Training and Implementation
        • 5.1.2.3.4. Others
    • 5.1.3. By Delivery Type
      • 5.1.3.1. On Premise
      • 5.1.3.2. Web and Cloud-based
    • 5.1.4. By Therapeutic Area
      • 5.1.4.1. Health and Wellness
      • 5.1.4.2. Chronic Disease Management
      • 5.1.4.3. Others
    • 5.1.5. By Functionality
      • 5.1.5.1. Communication
      • 5.1.5.2. Health Tracking and Insights
      • 5.1.5.3. Billing and Payments
      • 5.1.5.4. Administrative
      • 5.1.5.5. Patient Education
      • 5.1.5.6. Others
    • 5.1.6. By Application
      • 5.1.6.1. Population Health Management
      • 5.1.6.2. In-patient Health Management
      • 5.1.6.3. Outpatient Health Management
      • 5.1.6.4. Others
    • 5.1.7. By End-user
      • 5.1.7.1. Healthcare Providers
        • 5.1.7.1.1. Ambulatory Care Centers
        • 5.1.7.1.2. Home Healthcare Providers
        • 5.1.7.1.3. Hospitals
      • 5.1.7.2. Payers
        • 5.1.7.2.1. Public
        • 5.1.7.2.2. Private
      • 5.1.7.3. Patients
      • 5.1.7.4. Others
    • 5.1.8. United States*
      • 5.1.8.1. Market Size & Forecast
        • 5.1.8.1.1. By Value
      • 5.1.8.2. By Component
        • 5.1.8.2.1. Software
          • 5.1.8.2.1.1. Integrated Software
          • 5.1.8.2.1.2. Standalone Software
        • 5.1.8.2.2. Hardware
          • 5.1.8.2.2.1. Tablets
          • 5.1.8.2.2.2. In-Room Television
          • 5.1.8.2.2.3. Integrated Bedside Terminals/Assisted Devices
        • 5.1.8.2.3. Services
          • 5.1.8.2.3.1. Consulting
          • 5.1.8.2.3.2. Support and Maintenance
          • 5.1.8.2.3.3. Training and Implementation
          • 5.1.8.2.3.4. Others
      • 5.1.8.3. By Delivery Type
        • 5.1.8.3.1. On Premise
        • 5.1.8.3.2. Web and Cloud-based
      • 5.1.8.4. By Therapeutic Area
        • 5.1.8.4.1. Health and Wellness
        • 5.1.8.4.2. Chronic Disease Management
        • 5.1.8.4.3. Others
      • 5.1.8.5. By Functionality
        • 5.1.8.5.1. Communication
        • 5.1.8.5.2. Health Tracking and Insights
        • 5.1.8.5.3. Billing and Payments
        • 5.1.8.5.4. Administrative
        • 5.1.8.5.5. Patient Education
        • 5.1.8.5.6. Others
      • 5.1.8.6. By Application
        • 5.1.8.6.1. Population Health Management
        • 5.1.8.6.2. In-patient Health Management
        • 5.1.8.6.3. Outpatient Health Management
        • 5.1.8.6.4. Others
      • 5.1.8.7. By End-user
        • 5.1.8.7.1. Healthcare Providers
          • 5.1.8.7.1.1. Ambulatory Care Centers
          • 5.1.8.7.1.2. Home Healthcare Providers
          • 5.1.8.7.1.3. Hospitals
        • 5.1.8.7.2. Payers
          • 5.1.8.7.2.1. Public
          • 5.1.8.7.2.2. Private
        • 5.1.8.7.3. Patients
        • 5.1.8.7.4. Others
    • 5.1.9. Canada
    • 5.1.10. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Component
  • 6.2. By Delivery Type
  • 6.3. By Therapeutic Area
  • 6.4. By Functionality
  • 6.5. By Application
  • 6.6. By End-user
  • 6.7. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat From New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Oracle Corporation
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products and Services
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Key Market Focus and Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. IQVIA Holdings Inc.
  • 13.3. Koninklijke Philips N.V.
  • 13.4. Klara Technologies, Inc.
  • 13.5. Oneview Healthcare PLC
  • 13.6. Epic Systems Corporation
  • 13.7. Lincor Inc.
  • 13.8. Orion Health Ltd.
  • 13.9. MEDHOST Inc.
  • 13.10. Nuance Communications, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 3. Global Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 4. Global Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 5. Global Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 6. Global Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 7. Global Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 8. Global Patient Engagement Technology Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 11. North America Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 12. North America Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 13. North America Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 14. North America Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 15. North America Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 16. North America Patient Engagement Technology Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 19. United States Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 20. United States Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 21. United States Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 22. United States Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 23. United States Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 24. Canada Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 26. Canada Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 27. Canada Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 28. Canada Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 29. Canada Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 30. Canada Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 31. Mexico Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 33. Mexico Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 34. Mexico Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 35. Mexico Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 36. Mexico Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 37. Mexico Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 38. Europe Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 40. Europe Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 41. Europe Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 42. Europe Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 43. Europe Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 44. Europe Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 45. Europe Patient Engagement Technology Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 48. Germany Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 49. Germany Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 50. Germany Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 51. Germany Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 52. Germany Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 53. France Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 55. France Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 56. France Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 57. France Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 58. France Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 59. France Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 60. Italy Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 62. Italy Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 63. Italy Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 64. Italy Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 65. Italy Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 66. Italy Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 67. United Kingdom Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 69. United Kingdom Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 70. United Kingdom Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 71. United Kingdom Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 72. United Kingdom Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 73. United Kingdom Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 74. Russia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 76. Russia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 77. Russia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 78. Russia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 79. Russia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 80.
  • Figure 81. Russia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 82. Netherlands Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Netherlands Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 84. Netherlands Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 85. Netherlands Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 86. Netherlands Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 87. Netherlands Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 88. Netherlands Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 89. Spain Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 90. Spain Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 91. Spain Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 92. Spain Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 93. Spain Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 94. Spain Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 95. Spain Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 96. Turkey Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 97. Turkey Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 98. Turkey Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 99. Turkey Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 100. Turkey Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 101. Turkey Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 102. Turkey Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 103. Poland Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 104. Poland Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 105. Poland Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 106. Poland Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 107. Poland Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 108. Poland Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 109. Poland Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 110. South America Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 111. South America Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 112. South America Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 113. South America Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 114. South America Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 115. South America Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 116. South America Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 117. South America Patient Engagement Technology Market Share (%), By Country, 2017-2031F
  • Figure 118. Brazil Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 119. Brazil Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 120. Brazil Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 121. Brazil Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 122. Brazil Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 123. Brazil Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 124. Brazil Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 125. Argentina Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 126. Argentina Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 127. Argentina Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 128. Argentina Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 129. Argentina Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 130. Argentina Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 131. Argentina Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 132. Asia-Pacific Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Asia-Pacific Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 134. Asia-Pacific Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 135. Asia-Pacific Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 136. Asia-Pacific Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 137. Asia-Pacific Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 138. Asia-Pacific Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 139. Asia-Pacific Patient Engagement Technology Market Share (%), By Country, 2017-2031F
  • Figure 140. India Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 141. India Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 142. India Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 143. India Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 144. India Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 145. India Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 146. India Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 147. China Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 148. China Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 149. China Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 150. China Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 151. China Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 152. China Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 153. China Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 154. Japan Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 155. Japan Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 156. Japan Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 157. Japan Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 158. Japan Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 159. Japan Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 160. Japan Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 161. Australia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 162. Australia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 163. Australia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 164. Australia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 165. Australia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 166. Australia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 167. Australia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 168. Vietnam Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Vietnam Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 170. Vietnam Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 171. Vietnam Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 172. Vietnam Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 173. Vietnam Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 174. Vietnam Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 175. South Korea Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. South Korea Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 177. South Korea Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 178. South Korea Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 179. South Korea Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 180. South Korea Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 181. South Korea Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 182. Indonesia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 183. Indonesia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 184. Indonesia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 185. Indonesia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 186. Indonesia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 187. Indonesia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 188. Indonesia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 189. Philippines Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 190. Philippines Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 191. Philippines Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 192. Philippines Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 193. Philippines Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 194. Philippines Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 195. Philippines Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 196. Middle East & Africa Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 197. Middle East & Africa Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 198. Middle East & Africa Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 199. Middle East & Africa Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 200. Middle East & Africa Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 201. Middle East & Africa Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 202. Middle East & Africa Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 203. Middle East & Africa Patient Engagement Technology Market Share (%), By Country, 2017-2031F
  • Figure 204. Saudi Arabia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 205. Saudi Arabia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 206. Saudi Arabia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 207. Saudi Arabia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 208. Saudi Arabia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 209. Saudi Arabia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 210. Saudi Arabia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 211. UAE Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 212. UAE Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 213. UAE Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 214. UAE Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 215. UAE Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 216. UAE Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 217. UAE Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 218. South Africa Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
  • Figure 219. South Africa Patient Engagement Technology Market Share (%), By Component, 2017-2031F
  • Figure 220. South Africa Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
  • Figure 221. South Africa Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
  • Figure 222. South Africa Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
  • Figure 223. South Africa Patient Engagement Technology Market Share (%), By Application, 2017-2031F
  • Figure 224. South Africa Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
  • Figure 225. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Delivery Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Therapeutic Area Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By Functionality Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 230. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 231. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023